Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery—a Post Hoc Analysis of the FibroTest Prospective Study

[1]  V. de Lédinghen,et al.  New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. , 2019, Journal of hepatology.

[2]  T. Kuno,et al.  Effects of Bariatric Surgery on Cardiovascular Disease: A Concise Update of Recent Advances , 2019, Front. Cardiovasc. Med..

[3]  M. Anvari,et al.  Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta‐analysis , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  C. Tan,et al.  Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score , 2019, Obesity Surgery.

[5]  E. Muradova,et al.  Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. , 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[6]  R. Ehman,et al.  Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  H. Kenngott,et al.  Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up , 2018, Obesity Surgery.

[8]  C. Arvieux,et al.  Benefit-risk of intraoperative liver biopsy during bariatric surgery: review and perspectives. , 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[9]  E. Livingston,et al.  Bariatric Surgery and Long-term Durability of Weight Loss. , 2016, JAMA surgery.

[10]  Julien Vergniol,et al.  Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease. , 2016, Journal of hepatology.

[11]  H. Tilg,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. , 2016, Journal of hepatology.

[12]  European Association for the Study of the Liver,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease , 2016, Obesity Facts.

[13]  V. Wong,et al.  Nonalcoholic fatty liver disease , 2015, Nature Reviews Disease Primers.

[14]  F. Pattou,et al.  Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. , 2015, Gastroenterology.

[15]  E. Bugianesi,et al.  The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[16]  E. Livingston,et al.  Association between bariatric surgery and long-term survival. , 2015, JAMA.

[17]  M. Murr,et al.  Bariatric Surgery Improves Histological Features of Nonalcoholic Fatty Liver Disease and Liver Fibrosis , 2015, Journal of Gastrointestinal Surgery.

[18]  Joan Tordjman,et al.  Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients , 2012, Hepatology.

[19]  K. Clément,et al.  Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data , 2012, PloS one.

[20]  F. Pattou,et al.  Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity , 2011, European journal of gastroenterology & hepatology.

[21]  B. Neuschwander‐Tetri,et al.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.

[22]  V. de Lédinghen,et al.  Transient elastography for the diagnosis of liver fibrosis , 2010, Expert review of medical devices.

[23]  Julien Vergniol,et al.  Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease , 2010, Hepatology.

[24]  T. Barrientos-Gutiérrez,et al.  Bariatric surgery for non-alcoholic steatohepatitis in obese patients. , 2010, The Cochrane database of systematic reviews.

[25]  F. Pattou,et al.  Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. , 2009, Gastroenterology.

[26]  K. Kasturi,et al.  Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[27]  T. Poynard,et al.  Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience. , 2008, Journal of gastrointestinal and liver diseases : JGLD.

[28]  H. Cortez‐Pinto,et al.  Hepatic histology in obese patients undergoing bariatric surgery. , 2006, Journal of hepatology.

[29]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[30]  P. Giral,et al.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.

[31]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[32]  P. Shekelle,et al.  Meta-Analysis: Surgical Treatment of Obesity , 2005, Annals of Internal Medicine.

[33]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[34]  Claude Bouchard,et al.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.

[35]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[36]  P. Bedossa,et al.  Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .